SENSEX NIFTY

Glaxo

Sep 20, 2016 at 13:32 | Source: Reuters
Walmsley, who joined Britain's biggest drugmaker in 2010 from LOreal, will replace Andrew Witty who had previously announced his decision to retire on March 31, 2017.
Sep 19, 2016 at 12:02 | Source: PTI
"Suresh has over 30 years of experience in the pharmaceuticals market, having worked in India and Thailand for MNCs such as GlaxoSmithKline, Novartis, AstraZeneca and Pfizer. Over the years, he has played multiple leadership roles in Business Development, Marketing, Sales and Strategy," the company said in a statement.
Sep 15, 2016 at 19:49 | Source: Moneycontrol.com
Some investors shy away from buying stocks that have high prices. The belief is unfounded.
Sep 12, 2016 at 14:10 | Source: Reuters
The two firms, which have a long history of working together, said on Monday that Aspen would pay 180 million pounds for the products Ultiva, Nimbex, Tracrium, Mivacron and Anectinein, plus up to 100 million pounds in milestone payments.
Sep 12, 2016 at 10:22 | Source: PTI
The tie up between the drug maker and Verily, the health subsidiary of Google's parent company Alphabet, will focus on treatments for people living with the chronic disease.
Sep 01, 2016 at 08:01 | Source: CNBC-TV18
ACC | Ambuja Cement | India Cements | IOC | MCX | Ramco Cements | UltraTech Cement | Jaiprakash Associates | JK Cements | Tata Power | KEC International | Uniply Industries | C&C Constructions | Praj Industries | Esab India and Indo Rama Synthetics are stocks, which are in the news today.
Aug 31, 2016 at 12:40 | Source: CNBC-TV18
GSK had tried to sell the land parcel in 2014. But the deal fell through because of legal hurdles. Piramal Realty and K Raheja were frontrunners to buy the plot in 2014.
Aug 30, 2016 at 10:55 | Source: Moneycontrol.com
Be prepared. India is likely to see positive confidence shock with consumer discretionary and retail financiers to be benefitting the most. According to Abhay Laijawala of Deutsche Bank Multiple 7th Pay Commission, good monsoon, low interest rates and easing liquidity should provide a significant boost to aggregate demand in second half of FY17.
Aug 30, 2016 at 07:38 | Source: CNBC-TV18
Potential stock beneficiaries include Bajaj Finserv, GSK Consumer, Hero Motocorp, LIC Housing Finance, Titan Company and Whirlpool India, Abhay Laijawala of Deutsche Bank feels.
Aug 19, 2016 at 10:30 | Source: PTI
The second annual 'Change the World' list is topped by UK's GlaxoSmithkline, followed by Israel-based IDE Technologies and American conglomerate General Electric at the second and third positions, respectively.
Messages on Glaxo »

prashantnag
ori

Silver Member

9 Followers

GlaxoSmith Con  

Will you invest in GlaxoSmith Consumer for wealth creation in long term? Receive stock market updates for Free. http://t.in.com/fXVv

11.06 AM Sep 24th

Uresh Patel

New Member

0 Follower

Just Posted  

madam what about glaxo smithkline......? can i buy on this stage ?

2.14 PM Sep 23rd

arvind151

Platinum Member

77636 Followers

GlaxoSmith Con  

GlaxoSmithKline Consumer Healthcare- close below 6000 trend wil be bearish !!!

6.11 PM Sep 20th

Investor100
0

Platinum Member

518 Followers

GlaxoSmithKline  

Sell Glaxo Pharma for target of Rs 1800.

7.30 PM Sep 16th

Investor100
0

Platinum Member

518 Followers

GlaxoSmithKline  

Glaxo Pharma performance in the past is very poor. So why peoples can deploy fund in this very costly stock keeping in view of P/E.

7.29 PM Sep 16th

M.L. Chandel

New Member

21 Followers

GlaxoSmithKline  

Good support should be visible @2805-2815 on glaxo

2.36 PM Sep 16th

nirav4730

New Member

25 Followers

GlaxoSmithKline  

Accumulate Glaxo pharma with medium term target of 3500 and long term target of 4500 and above. Accumulate at all dips cmp 2900.

2.15 PM Sep 16th

b_udumbunth
ala

Silver Member

6 Followers

Syncom Formula  

manufacturing fecility , and SyncomFormula can market the product all over india, they can grow like Dabour. Please give new idea to promoters, management team, directors, top management. the prise of the share will go 100 rupee in three year time if SyncomFormula act like Dabour or Glaxo etc.

6.10 PM Sep 15th

manishgrove
r25

New Member

0 Follower

GlaxoSmithKline  

pls suggest someone, I ve been holding glaxo at 3000.what should be the strategy? Buy, sell or hold?

1.11 PM Sep 14th

BSE/NSE Announcer

Platinum Member

17373 Followers

GlaxoSmith Con  

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that In accordance with the Companys Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from September 15, 2016 and shall end 24 hours after declaration of Audited / Unaudited Financial

6.02 PM Sep 12th

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.